Ometor 20 mg (Capsule (Enteric Coated))

Unit Price: ৳ 4.00 (6 x 10: ৳ 240.00)
Strip Price: ৳ 40.00

Medicine Details

Category Details
Generic Omeprazole
Company Astra biopharmaceuticals ltd
Also available as

Indications

  • Gastric and duodenal ulcer
  • NSAID-associated duodenal and gastric ulcer
  • As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
  • Gastro-esophageal reflux disease
  • Long-term management of acid reflux disease
  • Acid-related dyspepsia
  • Severe ulcerating reflux esophagitis
  • Prophylaxis of acid aspiration during general anesthesia
  • Zollinger-Ellison syndrome
  • Helicobacter pylori-induced peptic ulcer

Pharmacology

  • Inhibitor of gastric acid secretion
  • Blocks hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system
  • Onset of antisecretory effect within one hour
  • Maximum effect occurring within two hours
  • Inhibition of secretion lasts up to 72 hours
  • Gradual return of secretory activity over 3 to 5 days after discontinuation

Dosage

  • 20 mg once daily for benign gastric and duodenal ulcer
  • 40 mg daily in severe or recurrent cases
  • 10-20 mg daily for prevention of relapse in duodenal ulcer
  • 20 mg once daily for NSAID-associated duodenal or gastric ulcer for 4-8 weeks
  • 40 mg once daily for gastro-esophageal reflux disease for 4-8 weeks
  • 10-20 mg daily for long-term management of acid reflux disease
  • 10-20 mg once daily for 2-4 weeks for acid-related dyspepsia
  • 40 mg on the preceding evening, then 40 mg 2-6 hours before surgery for prophylaxis of acid aspiration
  • Initially 60 mg once daily for Zollinger-Ellison syndrome, usual range 20-120 mg daily
  • 20 mg twice daily for Helicobacter pylori eradication regimen in peptic ulcer disease
  • 10-20 mg once daily for 4-12 weeks for severe ulcerating reflux esophagitis (Child>1 year)

Administration

  • IV Injection for prophylaxis of acid aspiration
  • IV Infusion over 20-30 minutes
  • Slow intravenous injection over at least 2 to 5 minutes at a maximum rate of 4 ml/minute
  • Use within 4 hours of reconstitution for IV injection
  • Use within 12 hours when dissolved in saline and within 6 hours when dissolved in 5% Dextrose for IV infusion
  • Reconstituted solution should not be mixed or co-administered with any other drug

Interaction

  • Decreased intragastric acidity may reduce the absorption of ketoconazole
  • Metabolized in the liver through cytochrome P450, can delay the elimination of diazepam, phenytoin and warfarin
  • Increased plasma concentrations during concomitant administration with clarithromycin for H. pylori eradication
  • No evidence of interaction with phenacetin, theophylline, caffeine, propranolol, metoprolol, cyclosporin, lidocaine, quinidine, estradiol, amoxycillin, antacids, alcohol or food

Contraindications

  • Known hypersensitivity to Omeprazole
  • Suspicion of gastric ulcer should exclude the possibility of malignancy before treatment

Side Effects

  • Skin rash, urticaria, pruritus
  • Photosensitivity, bullous eruption, erythema multiforme, angioedema, alopecia
  • Diarrhoea, headache
  • Gastrointestinal reactions: constipation, nausea/vomiting, flatulence, abdominal pain
  • Dry mouth, stomatitis, candidiasis
  • Paraesthesia, dizziness, lightheadedness, feeling faint
  • Somnolence, insomnia, vertigo
  • Reversible mental confusion, agitation, depression, hallucinations
  • Arthritic and myalgic symptoms
  • Blurred vision, taste disturbance, peripheral oedema, increased sweating, gynaecomastia
  • Leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, anaphylactic shock, malaise, fever
  • Hepatic effects: hepatitis with or without jaundice, interstitial nephritis, hepatic failure

Pregnancy & Lactation

  • No adverse effects on pregnancy or on the health of the fetus/newborn child in three prospective epidemiological studies
  • Use during pregnancy considered safe
  • No information available on the passage of Omeprazole into breast milk or its effects on the neonate
  • Breast-feeding should be discontinued if Omeprazole use is considered essential

Precautions & Warnings

  • Avoid concomitant use with clopidogrel
  • PPI therapy may be associated with an increased risk for osteoporosis-related fractures
  • Atrophic gastritis noted occasionally in patients treated long-term
  • Concomitant use with methotrexate may lead to methotrexate toxicities

Therapeutic Class

Proton Pump Inhibitor

Storage Conditions

Keep in a dry place away from light and heat, keep out of the reach of children

Related Brands